AI in Drug Discovery: From Target Identification to Clinical Prediction
Description
Strategic analysis of AI-driven drug discovery showing 40%+ success rate improvements. Global drug discovery market growing 14.9% CAGR. Covers R&D productivity transformation, talent acquisition, and ROI timeline for enterprise AI deployment.
Table of Contents
75 Pages
- EXECUTIVE SUMMARY
- 1.1 AI in Drug Discovery Market Overview
- 1.2 AI-Driven Program Success Metrics
- 2.0 DRUG DISCOVERY WORKFLOW TRANSFORMATION
- 2.1 Target Identification AI
- 2.2 Compound Screening Optimization
- 2.3 Toxicity & Safety Prediction
- 3.0 CLINICAL TRIAL PREDICTION
- 3.1 Patient Selection AI
- 3.2 Response Prediction Models
- 3.3 Safety Signal Detection
- 4.0 ORGANIZATIONAL CAPABILITIES
- 4.1 Talent Acquisition & Training
- 4.2 Workflow Integration Strategy
- 4.3 Data Quality Management
- 5.0 REGULATORY & IMPLEMENTATION
- 5.1 FDA Expectations for AI-Designed Drugs
- 5.2 Model Validation & Transparency
- 5.3 ROI Timeline & Investment Case
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


